CSL has previously indicated it is interested in mRNA development, but not until into the future once its current production requirements are behind it.


The CSL spokeswoman said the company is in talks with the government about its role in the pandemic after it completes its AstraZeneca production run, however.

“Conversations with the Australian Government about ways CSL can support the COVID-19 vaccination program are ongoing, and following completion of the AstraZeneca vaccine campaign, CSL would, if requested by the Australian Government, reassess its ability to manufacture other vaccines,” she said.

A number of new candidates and COVID booster shots could flow into the Australian market in the coming years, including the Novavax vaccine, for which final data is expected in the coming weeks.

Source link